These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1462834

  • 1. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [Abstract] [Full Text] [Related]

  • 2. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay.
    Levi M, de Boer JP, Roem D, ten Cate JW, Hack CE.
    Thromb Haemost; 1992 Jan 23; 67(1):111-6. PubMed ID: 1377412
    [Abstract] [Full Text] [Related]

  • 5. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H, Miyata T, Iwanaga S, Yamamoto T.
    Thromb Haemost; 1992 Apr 02; 67(4):440-4. PubMed ID: 1631792
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Apr 02; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 7. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M, Lensing AW, Büller HR, Prandoni P, Dooijewaard G, Cuppini S, ten Cate JW.
    Thromb Haemost; 1991 Oct 01; 66(4):426-9. PubMed ID: 1796391
    [Abstract] [Full Text] [Related]

  • 8. DDAVP induces systemic release of urokinase-type plasminogen activator.
    Levi M, ten Cate JW, Dooijewaard G, Sturk A, Brommer EJ, Agnelli G.
    Thromb Haemost; 1989 Sep 29; 62(2):686-9. PubMed ID: 2510348
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F, Castaman G, Ruggeri M, Cazzavillan M, Ferracin G, Dini E.
    Haematologica; 1991 Sep 29; 76(1):28-32. PubMed ID: 2055558
    [Abstract] [Full Text] [Related]

  • 10. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ, Dooijewaard G, Turion PN.
    Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069
    [Abstract] [Full Text] [Related]

  • 11. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC.
    Thromb Haemost; 1979 Jun 30; 41(4):756-73. PubMed ID: 483248
    [Abstract] [Full Text] [Related]

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 13. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K, Letowska M, Sabliński J, Binder BR, Kopeć M, Lopaciuk S.
    Acta Haematol Pol; 1994 Dec 22; 25(3):261-8. PubMed ID: 7992599
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 22; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 15. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease.
    Sultan Y, Loyer F, Venot A.
    Nouv Rev Fr Hematol (1978); 1992 Dec 22; 34(1):55-60. PubMed ID: 1523100
    [Abstract] [Full Text] [Related]

  • 16. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M, Miyashita C.
    Klin Wochenschr; 1988 Dec 22; 66 Suppl 12():62-7. PubMed ID: 3126347
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Dec 22; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 18. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A, Iwan-Zietek I, Kotschy M, Gwieździński Z.
    Med Sci Monit; 2002 Mar 22; 8(3):CR189-92. PubMed ID: 11887034
    [Abstract] [Full Text] [Related]

  • 19. Homozygous type I plasminogen deficiency.
    Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V.
    Semin Thromb Hemost; 1997 Mar 22; 23(3):259-69. PubMed ID: 9255907
    [Abstract] [Full Text] [Related]

  • 20. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007 Mar 22; 119(4):475-80. PubMed ID: 16828495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.